¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"secondary macula atrophy"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • secondary gout
    ÀÌÂ÷Åëdz
  • secondary hemorrhage
    ¼Ó¹ßÃâÇ÷, ÀÌÂ÷ÃâÇ÷
  • secondary hypertension
    ÀÌÂ÷°íÇ÷¾Ð
  • secondary hypogonadism
    ¼Ó¹ß»ý½Ä»ùÀúÇÏÁõ, ¼Ó¹ß»ý½Ä¼±ÀúÇÏÁõ
  • secondary immune response
    ÀÌÂ÷¸é¿ª¹ÝÀÀ
  • secondary infection
    ÀÌÂ÷°¨¿°, ¼Ó¹ß°¨¿°
  • secondary keratitis
    ¼Ó¹ß°¢¸·¿°
  • secondary lysosome
    ÀÌÂ÷¿ëÇØ¼Òü
  • secondary nodule
    Á¾ÀÚÁß½É, ¹èÁß½É
  • secondary pneumonia
    ¼Ó¹ßÆó·Å
  • secondary process thinking
    ÀÌÂ÷°úÁ¤»ç°í
  • secondary sequestrum
    ÀÌÂ÷ºÎ°ñ, ºÎºÐºÐ¸®Á×Àº»À
  • secondary sex characteristic
    ÀÌÂ÷¼ºÂ¡
  • secondary sexual character
    ÀÌÂ÷¼ºÂ¡
  • secondary shock
    ÀÌÂ÷¼îÅ©, ¼Ó¹ß¼îÅ©
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • back pressure renal atrophy
    ¿ª¾ÐÄáÆÏÀ§Ãà, ¿ª¾Ð½ÅÀ§Ãà
  • cicatrical atrophy
    ÈäÅÍÀ§Ãà
  • correlated atrophy
    »ó°üÀ§Ãà
  • cortical atrophy
    °ÑÁúÀ§Ãà
  • cyanotic atrophy
    û»öÁõÀ§Ãà
  • denervation atrophy
    Å»½Å°æÀ§Ãà
  • disuse atrophy
    ºÒ»ç¿ëÀ§Ãà
  • eccentric atrophy
    Æí½ÉÀ§Ãà
  • facial atrophy
    ¾ó±¼À§Ãà, ¾È¸éÀ§Ãà
  • fat atrophy
    Áö¹æÀ§Ãà
  • geographic atrophy
    ÁöµµÇüÀ§Ãà
  • halisteretic atrophy
    ŻȸÀ§Ãà
  • lactation atrophy
    ¼öÀ¯À§Ãà, Á¥ºÐºñÀ§Ãà
  • macular atrophy
    (¢¡anetoderma) ÇǺÎÀ§ÃàÁõ
  • mast atrophy
    À¯¹æÀ§Ãà
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • infantile muscular atrophy =Werdnig-Hoffmann disease
    ¿µ¾ÆÇü ±ÙÀ§ÃàÁõ(?ä®û¡ÐÉê×õêñø).
  • infantile progressive spinal muscular atrophy
    ¿µ¾ÆÁøÇ༺ ô¼ö¼º ±ÙÀ§Ãà(Áõ).
  • peroneal muscular atrophy
    ºñ°ñ±Ù À§ÃàÁõ(ÝëÍéÐÉê×õêñø).
  • pigmentary atrophy
    »ö¼Ò¼º À§Ãà(ßäáÈàõ ê×õê)
  • postinflammatory optic atrophy
    ¿°ÁõÈĽýŰæÀ§Ãà
  • postneuritic optic atrophy
    ¿°ÁõÈĽýŰæÀ§Ãà
  • pressure atrophy
    ¾Ð¹ÚÀ§Ãà(äâÚÞê×õê).
  • primary optic atrophy
    ¿ø¹ß½Ã½Å°æÀ§Ãà(ê«Û¡ãÊãêÌèê×õê).
  • primary optic atrophy
    ¿ø¹ß(¼º) ½Ã½Å°æÀ§Ãà(ê«Û¡(àõ) ãÊãêÌèê×õê)
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(¡­ãêÌèàõÐÉê×õê).
  • progressive neural muscular atrophy
    ÁøÇ༺ ½Å°æ¼º ±ÙÀ§Ãà(òäú¼àõ ãêÌèàõ ÐÉê×õê)
  • progressive unilateral facial atrophy
    ÁøÇ༺ Æí¾È¸éÀ§Ãà(òäú¼àõø¸äÔØüê×õê ).
  • progressive unilateral facial atrophy
    ÁøÇ༺ Æí¾È¸éÀ§Ãà(òäú¼àõ ø¸äÔØüê×õê )
  • red atrophy
    Àû»öÀ§Ãà(îåßäê×õê)
  • renal atrophy
    ½ÅÀ§Ãà(ãìê×õê).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • macula cribrosa superior <³ª>
    »ó»ç(»ó)¹Ý, À§Ã¼ÆòÇüü¹Ý{ÇØ}
  • macula cribrosa superior ³ª
    À§Ã¼ÆòÇüü¹Ý, »ó»ç»ó¹Ý(ß¾ÞèßÒÚè).
  • macula cribrosa ³ª
    »ç»ó¹Ý(ÞèßÒÚè).
  • macula densa
    Ä¡¹Ð¹ÝÁ¡
  • macula densa cell
    ¹ÐÁý¹Ý¼¼Æ÷(ÚËó¢Úèá¬øà).
  • macula densa cell
    Ä¡¹Ð¹ÝÁ¡¼¼Æ÷
  • macula densa ³ª
    Ä¡¹Ð¹Ý, ¹ÐÁý¹Ý(ÚËó¢Úè).
  • macula flava ³ª
    Ȳ¹Ý(üÜÚè).
  • macula folliculi ³ª
    ³­Æ÷¹Ý(Õ°øàÚè).
  • macula germinativa ³ª
    ¹èÀÚ¹Ý, ¹è¹Ý(ÛÏÚè).
  • macula lactea
    ±â¸§Á×¹ÝÁ¡
  • macula lactea ³ª
    À¯¹Ì¹Ý, À¯¾ç¹Ý(êáåÆÚè).
  • macula lutea ³ª
    (¸Á¸·)Ȳ¹Ý(ØÑدüÜÚè).
  • macula occludens ³ª
    Æó¼â¹Ý(øÍáðÚè).
  • macula of cornea
    °¢¸·¹Ý(ÊÇØ¯Úè).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Secondary osteogenic bud
    ÀÌÂ÷»À¹ß»ý½Ï
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÇü¼º¾Æ
  • Secondary ossification center
    ÀÌÂ÷»À¹ß»ýÁß½É
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÈ­Áß½É
  • Secondary ossification center [Epiphyseal ossification cente
    ÀÌÂ÷»À¹ß»ýÁ᫐ [»À³¡»À¹ß»ýÁß½É]
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñÈ­Áß½É
  • Secondary bone trabecula
    ÀÌÂ÷»ÀÀܱâµÕ
    [¿¾ ¿ë¾î] ÀÌÂ÷°ñ¼ÒÁÖ
  • Secondary dentin
    ÀÌÂ÷»ó¾ÆÁú
    [¿¾ ¿ë¾î] ÀÌÂ÷»ó¾ÆÁú
  • Secondary nodule
    ÀÌÂ÷¼ÒÀý
    [¿¾ ¿ë¾î] ÀÌÂ÷¼ÒÀý
  • Secondary villus
    ÀÌÂ÷À¶¸ð
    [¿¾ ¿ë¾î] ÀÌÂ÷À¶¸ð
  • Secondary pregnancy
    ÀÌÂ÷ÀÓ½Å
    [¿¾ ¿ë¾î] ÀÌÂ÷ÀÓ½Å
  • Secondary spermatocyte
    ÀÌÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] ÀÌÂ÷Á¤¸ð¼¼Æ÷
  • Secondary spermatocyte
    ÀÌÂ÷Á¤¸ð¼¼Æ÷
    [¿¾ ¿ë¾î] Á¦ÀÌÁ¤¸ð¼¼Æ÷
  • Secondary nasal septum
    ÀÌÂ÷ÄÚÁß°Ý
    [¿¾ ¿ë¾î] ÀÌÂ÷ºñÁß°Ý
  • Secondary hair follicle
    ÀÌÂ÷ÅÐÁÖ¸Ó´Ï
    [¿¾ ¿ë¾î] ÀÌÂ÷¸ð³¶
  • Secondary sponge bone
    ÀÌÂ÷ÇØ¸é»À
    [¿¾ ¿ë¾î] ÀÌÂ÷ÇØ¸é°ñ
  • Secondary pulmonary lobule
    ÀÌÂ÷ÇãÆÄ¼Ò¿±
    [¿¾ ¿ë¾î] ÀÌÂ÷Æó¼Ò¿±
  • Palatine process [Secondary palate]
    ÀÔõÀåµ¹±â [ÀÌÂ÷ÀÔõÀå]
    [¿¾ ¿ë¾î] ±¸°³µ¹±â(ÀÌÂ÷±¸°³)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SEM sample evaluation method; scanning electron microscopy; secondary enrichment medium; standard error ...
SGE secondary generalized epilepsy
SHO secondary hypertrophic osteoarthropathy; Senior House Officer
SHP Schonlein-Henoch purpura; secondary hyperparathyroidism; state health plan
sHPT secondary hyperparathyroidism
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
SHPT secondary hyperparathyroidism
SMC secondary mesenchyme cell
SP-MS secondary progressive MS
CA Cerebellar atrophy
CA Cerebral atrophy
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • reticular atrophy
    ¸Á»ó À§Ãà
  • senile atrophy
    ³ë³â¼º À§Ãà, ³ëÀμº À§Ãà
    ³ªÀ̰¡ µê¿¡ µû¸¥ ¸ðµç Á¶Á÷ÀÇ »ý¸®ÀûÀÎ À§Ãà.
  • spinal progressive muscular atrophy
    ô¼ö¼º ÁøÇ༺ ±ÙÀ§ÃàÁõ
    ô¼ö ¹× ¿¬¼öÀÇ ¿îµ¿ ½Å°æ ¼¼Æ÷ÀÇ º¯¼º¿¡ ÀÇÇÏ¿© Àü½ÅÀÇ ±ÙÀ§Ãà°ú Å»·ÂÀ» ÀÏÀ¸Å°´Â º´. ¼Õ, ¹ßÀÇ ±ÙÀ° À§Ãà¿¡¼­ ½ÃÀÛÇÏ¿© Á¡Â÷·Î »óÇàÇØ¼­ ¸ñÀÇ ±ÙÀ°°ú ¸öÅëÀÇ ±ÙÀ°µµ Ä§ÇØµÈ´Ù. »ó, ÇÏÁöÀÇ ÈûÁٹݻ簡 ¾àÇØÁö°í ¹Ùºó½ºÅ° ¹Ý»ç´Â À½¼ºÀÌ µÈ´Ù. °æ°ú°¡ ±æ°í Á¶±â¿¡ »ç¸ÁÇÏ´Â ÀÏÀº ¾øÀ¸³ª, °«³­¾Æ±â¿¡¼­ º¼ ¼ö ÀÖ´Â ÀÌ º´À» º£¸£Æ®´ÏÈ÷-È£ÇÁ¸¸ º´À̶ó°í Çϸç, ¼ö³â À̳»¿¡ »ç¸ÁÇÑ´Ù. ¶Ç À̰Ͱú ±Ù¿¬°ü°è¿¡ ÀÖ´Â °¡Á·¼º ô¼ö¼º ±ÙÀ§¼º ±Ù À§ÃàÁõµµ ÀÌ º´ÀÇ ÇÑ ÇüÀÌ´Ù. 3¼¼ ÀÌÈÄÀÇ ¾î´À ¿¬·ÉÃþ¿¡¼­³ª ¹ßº´ÇÏ¸ç ±ä °æ°ú¸¦ ÃëÇÑ´Ù. Ư¼öÇÑ Ä¡·á¹ýÀº ¾ø°í ¿îµ¿ ¿ä¹ýÀÌ ÇÊ¿äÇÏ´Ù.
  • Zimmerlin's atrophy
    Áü¸Þ¸¦¸° À§Ãà
  • brain vesicle`s secondary
    ÀÌÂ÷ ³úÆ÷
    Èı⠹èÅ ºÐÈ­·Î Çü¼ºµÇ´Â ³× °³ÀÇ ³ú³¶À¸·Î¼­ Àü³ú·ÎºÎÅÍ ºÐÈ­µÇ´Â Á¾³ú¿Í °£³ú, ´É³ú·ÎºÎÅÍ ºÐÈ­µÇ´Â Èijú¿Í ¼ö³ú¸¦ Æ÷ÇÔÇÑ´Ù.
  • secondary activation
    ÀÌÂ÷Àû Ȱ¼º
  • secondary amine
    ÀÌÂ÷ ¾Æ¹Î
  • secondary anemia
    ¼Ó¹ß¼º ºóÇ÷
  • secondary bond
    ÀÌÂ÷ °áÇÕ
    ÀϹÝÀûÀ¸·Î ¼ö¼Ò °áÇÕ, ¹Ýµ¥¸£¹ß½º Èû µîÀ» ¸»ÇÏ¸ç °áÇÕ·ÂÀº ÀÏÂ÷ °áÇշ¿¡ ºñÇÏ¸é ¸Å¿ì ÀÛ´Ù
  • secondary caries
    ÀÌÂ÷ ¿ì½Ä
    ½ÉºÎ¿¡ ¹ÌÄ£ ¹ý¶ûÁú ¿ì½ÄÀÌ »ó¾ÆÁú °æ°è¸¦ ¿·À¸·Î ÆÛÁ®¼­ °Å²Ù·Î Ç¥¸éÂÊÀ¸·Î ÁøÇàÇÏ´Â ¿ì½Ä. ¿ì½ÄÀ» ÃæÀüÇÑ ÈÄ ±× º¯¿¬¿¡¼­ ´Ù½Ã ÀϾ´Â ¿ì½Ä.
  • secondary cementum
    ÀÌÂ÷ ¹é¾ÇÁú, Á¦2¹é¾ÇÁú
    ÀÏÂ÷ ¹é¾ÇÁú ÀÌÈÄ¿¡ Çü¼ºµÈ ¸ðµç ÃþÀ» °¡¸®Å°´Â ¿ë¾î. ¼¼Æ÷¼º ȤÀº ºñ¼¼Æ÷¼ºÀÌ´Ù.
  • secondary crown
    ¿Ü°ü
  • secondary dentin formation
    ÀÌÂ÷ »ó¾ÆÁú Çü¼º
    Åë»óÀûÀÎ ±â´ÉÀû ±×¸®°í ¿­ ÀûÀÎ Àڱؿ¡ ´ëÇÑ Á¡Â÷ÀûÀÎ Ãß°¡Àû »ó¾ÆÁú Çü¼ºÀÌ¸ç ¹æ»ç¼± »çÁø »óÀ¸·Î Ä¡°üºÎ »ó¾ÆÁú µÎ²²ÀÇ ±ÕÀÏÇÑ Áõ°¡ ¾ç»óÀ» º¸À̰í ÀÖ´Ù. ´ëºÎºÐÀÇ ¼ºÀο¡´Â ÀÌ·¯ÇÑ °úÁ¤ÀÌ Á¸ÀçÇϸç ÀÌÀÇ Á¤µµ´Â °³Àο¡ µû¶ó ´Ù¾çÇÏ´Ù. 2Â÷ »ó¾ÆÁúÀº Ä¡¾Æ Ç¥¸é¿¡¼­ Ä¡¼ö±îÁö ¿ì½Ä º´º¯ÀÌ ÁøÇàµÇ´Âµ¥ °É¸®´Â ½Ã°£°ú °Å¸®¸¦ Áõ°¡½ÃŰ°Ô µÈ´Ù. ¶ÇÇÑ Ä¡¼ö°¢°ú °°Àº Ç¥ÃþÀÇ Ä¡¼ö Á¶Á÷À» ¸ÍÃâ ÈÄ ¼ö³â À̳»¿¡ 2Â÷ »ó¾ÆÁú·Î ´ëÄ¡½ÃÅ´À¸·Î½á ¼öº¹ ½Ã¼ú ½Ã ±â°èÀûÀÎ Ä¡¼ö ³ëÃâ °¡´É¼ºÀ» °¨¼Ò½ÃŲ´Ù. ÇÑÆí Àڱؿ¡ ´ëÇÑ Ä¡¼öÀÇ ¹Î°¨¼ºÀ» °¨¼Ò½Ã۱⠶§¹®¿¡ Ä¡¼ö °Ë»ç¿Í Ä¡¾Æ ÁúȯÀÇ Áø´Ü ½Ã À̰ÍÀÌ °í·ÁµÇ¾î¾ß ÇÑ´Ù.
  • secondary diagnosis
    ÀÌÂ÷ Áø´Ü
  • secondary disorder
    ÀÌÂ÷ Àå¾Ö
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
alveolar atrophy Diminution in size of the supportive tissues of the teeth due to lack of function, reduced blood supply, or unknown causes.
(05 Mar 2000)
arthritic atrophy Atrophy of muscles rendered inactive by a chronically inflamed or fixed joint.
(05 Mar 2000)
atrophy <pathology> A wasting away, a diminution in the size of a cell, tissue, organ or part.
Origin: L., Gr. Atrophia
(16 Dec 1997)
back-pressure renal atrophy <radiology> Caliectasis without obstruction, due to repeated episodes of obstruction, gradual loss of renal pyramids
(12 Dec 1998)
blue atrophy Depressed blue atrophic scars due to injections in the skin of impure substances, as seen in narcotics addicts.
(05 Mar 2000)
brown atrophy Atrophy of the heart wall, especially in the elderly, in which the muscle is dark reddish brown and reduced in volume; the muscle fibres become pigmented especially about the nuclei, by lipochrome granules.
(05 Mar 2000)
Buchwald's atrophy A progressive form of cutaneous atrophy.
(05 Mar 2000)
macular atrophy Atrophoderma in which the skin becomes bag like and wrinkled.
Synonym: atrophia maculosa varioliformis cutis, atrophoderma maculatum, macular atrophy, primary idiopathic macular atrophy, primary macular atrophy of skin.
Origin: G. Anetos, relaxed, + derma, skin
(05 Mar 2000)
gastric atrophy <gastroenterology> A condition in which the stomach muscles shrink and become weak. It results in a lack of digestive juices. Gastritis: Inflammation of the stomach.
(12 Dec 1998)
marantic atrophy <medicine> A wasting of flesh without fever or apparent disease; a kind of consumption; atrophy; phthisis. "Pining atrophy, Marasmus, and wide-wasting pestilence." (Milton) Marasmus senilis [L], progressive atrophy of the aged.
Origin: NL, fr. Gr, fr, to quench, as fire; pass, to die away.
Source: Websters Dictionary
(01 Mar 1998)
red atrophy Atrophy due to destruction of the parenchymatous cells of an organ as a consequence of chronic venous congestion.
Synonym: red atrophy.
(05 Mar 2000)
gingival atrophy The exposure of root surface by an apical shift in the position of the gingiva.
(12 Dec 1998)
villous atrophy Abnormality of the small intestinal mucosa with crypt hyperplasia, resulting in flattening of the mucosa and the appearance of atrophy of villi; clinically seen in malabsorption syndromes such as sprue.
(05 Mar 2000)
central areolar choroidal atrophy A slowly progressive pigmentary degeneration in young persons; characterised by black foci closely set together and coalescent at the posterior pole and macular region.
Synonym: central areolar choroidal atrophy, central areolar choroidal sclerosis.
(05 Mar 2000)
Vulpian's atrophy Progressive spinal muscular atrophy beginning in the shoulder.
Synonym: scapulohumeral atrophy.
(05 Mar 2000)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á